Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah J. Wilkens"'
Autor:
Carmel Bogle, Amanda Marma Perak, Sarah J. Wilkens, Alaa Aljiffry, Karen Rychlik, John M. Costello, Donald M. Lloyd-Jones, Elfriede Pahl
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Ideal “cardiovascular health” (CVH)–optimal diet, exercise, nonsmoking, BMI, BP, lipids, and glucose—is associated with healthy longevity in adults. Pediatric heart transplant (HT) patients may be at risk for suboptimal CV
Externí odkaz:
https://doaj.org/article/9237683c997041d3b34508593752f432
Publikováno v:
Pediatric Cardiology. 42:1653-1657
While the Norwood operation is the most common palliative surgery for neonates with hypoplastic left heart syndrome (HLHS), initial hybrid strategy aiming to restrict pulmonary blood flow and maintain systemic output is necessary when Norwood is cont
Autor:
C. Bogle, A. Marma Perak, Sarah J Wilkens, Karen Rychlik, Don Lloyd-jones, John M. Costello, Elfriede Pahl, A. Aljiffry
Publikováno v:
BMC Cardiovascular Disorders. 22
Background Ideal “cardiovascular health” (CVH)–optimal diet, exercise, nonsmoking, BMI, BP, lipids, and glucose—is associated with healthy longevity in adults. Pediatric heart transplant (HT) patients may be at risk for suboptimal CVH. Method
Autor:
David N. Rosenthal, Seth A. Hollander, L. Barkoff, Sarah J. Wilkens, Beth D. Kaufman, James R. Priest
Publikováno v:
Pediatric transplantationREFERENCES. 24(1)
Purpose We sought to determine whether the presence of a systemic SA with potential complicating factors affects waitlist and post-HT outcomes in pediatric patients. Methods This is a single-center retrospective review of pediatric patients listed fo
Autor:
Yulin Zhang, Doff B. McElhinney, Joanne Lee, Stephen J. Roth, David N. Rosenthal, Fred Nishioka, Jenna Murray, Sarah J. Wilkens, Christopher S. Almond, Daniel J. Murphy
Publikováno v:
Journal of the American College of Cardiology. 71:A609
Studies suggest that tighter INR control can be achieved with a centralized pharmacist-led warfarin monitoring program. No data are available in children with cardiac disease where the age of patients varies significantly and high-risk indications ar